NASDAQ · AVAH

Aveanna Healthcare Holdings Inc.

$9.67 +$0.22 (+2.33%) 1D After hours

Key Metrics

$2.06B
Market cap
7.87×
P/E · TTM
$2.52B
Revenue · TTM
$261.49M
Net income
EPS · TTM $1.27
Dividend yield
Free cash flow
Beta · 1Y 0.87
EBITDA · TTM
Gross margin 33.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 14
    The stock moved +9.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 14
  • Apr 10
    From its Feb 3 high, the share price fell 26%.

    Peak close $8.46 on Feb 3; trough close $6.22 on Apr 10. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -26%
  • Mar 19
    The stock moved -8.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 19

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.06B
Enterprise value$3.17B
Shares outstanding217.8M
52-wk range$3.73 – $10.32
Avg volume · 20D587.6K
Net cash −$1.11B
Book value / share$1.16
IndustryServices-Home Health Care Services
ExchangeNASDAQ
About Aveanna Healthcare Holdings Inc.
IPO dateApr 29, 2021
Employees35500

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E7.87
P/S0.82
P/FCF
EV/EBITDA
EV/Sales1.26
Graham №$5.76

Profitability

Gross 33.0%
Operating 5.6%
Net 10.4%
FCF
ROE / ROIC 448.9% · 19.4%

Financial Health

Current ratio1.47
Quick ratio
Debt / equity5.40
Debt / EBITDA
Net cash −$1.11B
Working capital$184.87M

Cash Flow · TTM

Operating CF $138.84M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

1.5
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$5.76 vs $9.67
Trades 1.7× above classic defensive value — priced for growth
Fundamentals through 2026-04-04 · computed by TickerWolf from SEC filings